Stryker and Johnson & Johnson, two medical device manufacturers accused of making defective hip implants, have recently settled hip device lawsuits. Even though some settlements are being reached with hip device companies, recipients of defective hip implants who have not filed a claim are still eligible to seek compensation for defective hip implants.
Stryker Corp., a Fortune 500 medical device company, recently announced that it settled four Rejuvenate and ABG II hip implant lawsuits in New Jersey. The hip implant legal claims were settled for an undisclosed amount of money. Stryker faces approximately 1,000 lawsuits – a number that continues to grow – related to problems with its hip implants.
The Kalamazoo, Mich.-based company’s products are alleged to cause serious and potentially dangerous side effects such as metal poisoning. Some defective hip implant patients have needed revision surgery to remove the implant, which creates a separate set of risks. Stryker recalled its ABG II and Rejuvenate hips in June 2012 due to the risk of corrosion and metal poisoning.
Last November, Johnson & Johnson announced a $2.5 billion settlement agreement over its own defective hip implants. The settlement agreement proposes to resolve 8,000 claims filed by patients who received Johnson & Johnson’s defective DePuy Articular Surface Replacement (ASR) Hip System devices. Under the settlement plan, the typical patient payment for pain and suffering caused by the faulty hip implant would be approximately $250,000 before fees, according to the New York Times. Internal documents revealed that DePuy Orthopaedics estimated that the hip implant would fail within five years in 40 percent of patients who received it.
At The Cochran Firm, D.C., we continue to accept cases from clients who have received defective hip implants. Our seasoned hip implant attorneys can guide you through the complex legal process and design a case strategy aimed at securing you the highest compensation possible. Contact us today to receive a free consultation. All initial case evaluations are free, confidential, and carry no obligation.